跳至主要内容
临床试验/PACTR201310000484185
PACTR201310000484185已完成未知

Artemether-lumefantrine versus Artesunate-amodiaquine for treatment of uncomplicated plasmodium falciparum malaria in pregnancy; A randomized control trial.

kah Chukwuemeka Marcel0 个研究点目标入组 150 人开始时间: 2013年1月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Year(s) 至 49 Year(s)(—)
性别
Female

入选标准

  • 1.Symptoms of malaria such as fever (T 37.5oc), headaches, body pains within 24 hours before presentation.
  • 2.Microscopically-confirmed P. falciparum malaria with parasitaemia of at least one plus (1-10 parasites/100 thick film field).
  • 3.Consent to participate in the study
  • 4.Willingness/ability to comply with follow-up schedule

排除标准

  • 1.Severe malaria or danger signs of severe malaria (e.g. loss of consciousness, convulsions, anuria)
  • 2.Women in the first trimester of pregnancy
  • 3.Use of any anti-malarial drug other than sulphadoxine pyrimethamine less than 7 days before presentation
  • 4.Other concurrent pregnancy related diseases e.g. urinary tract infections.
  • 5.History of reaction to any of the drugs.
  • 6.Patients not tolerating orally.

研究者

发起方
kah Chukwuemeka Marcel

相似试验